Fabian Hink

Fabian Hink is a Postdoctoral Researcher (academic rank: Researcher) in the Department of Drug Design and Pharmacology at the Faculty of Health and Medical Sciences, University of Copenhagen. His research focuses on computational approaches to protein and peptide-based drug design, with applications in neuropharmacology and stroke treatment.

His primary research interests include Computational Biology, Structural Biology, Protein Engineering, and Machine Learning. He specializes in developing computational tools for de novo protein design, targeting ion channels and helical peptides to create novel therapeutics. His work bridges structural bioinformatics with experimental pharmacology to address neurological disorders.

Analysis of his 2024-2025 publications reveals a strong emphasis on leveraging deep learning for protein binder design, particularly targeting sodium channels (ASIC1a) for stroke intervention. His research integrates structural biology, peptide chemistry, and computational modeling to develop miniprotein modulators and helix-stabilizing macrocycles.

No information on scientific awards was provided in the available text.

No details regarding student advising or research grants were available in the source material.

Hink collaborates extensively with interdisciplinary teams, including researchers Dr. Rogers and Dr. Pless, as evidenced by multi-institutional publications in high-impact journals like Nature and Journal of the American Chemical Society. His work demonstrates significant translational potential, with publications receiving attention from news outlets and clinical guideline sources.